Transcenta (6628 HK)

Transcenta is a clinical-stage biopharmaceutical company with integrated capabilities in the discovery, research, development, manufacturing, and business development of biopharmaceuticals. The company develops therapeutic antibody molecules for oncology and selected non-oncology indications, including bone and kidney disorders, and also provides contract development and manufacturing organization (CDMO) services. Transcenta is headquartered in Suzhou, China, and was founded in 2010.